Halozyme Therapeutics | L'Utile Operativo



Operating Profit Cambiamento Data
Acadia Pharmaceuticals USD 153.5M 121.86M 2024-12
Agios Pharmaceuticals USD -125037000 1.11B 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amarin USD -25168000 24.64M 2024-09
Amgen USD 2.31B 182M 2024-12
Baxter International USD -435000000 590M 2024-12
Cytokinetics USD -139040000 1.76M 2024-12
DBV Technologies USD -30328000 3.51M 2024-09
Eli Lilly USD 5.15B 3.62B 2024-12
Halozyme Therapeutics USD 175.5M 12.3M 2024-12
Indivior 94M 226M 2024-09
Intra Cellular Therapies USD -29197000 9.65M 2024-12
Ionis Pharmaceuticals USD -110823000 37.83M 2024-12
MannKind USD 13.1M 4.92M 2024-12
Pfizer USD -409000000 5.57B 2024-12
United Therapeutics USD 357.7M 14.6M 2024-12



Halozyme Therapeutics L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.